JPH07165709A - カルボキシアミド及びアニリドならびに医薬品へのその利用 - Google Patents

カルボキシアミド及びアニリドならびに医薬品へのその利用

Info

Publication number
JPH07165709A
JPH07165709A JP4090152A JP9015292A JPH07165709A JP H07165709 A JPH07165709 A JP H07165709A JP 4090152 A JP4090152 A JP 4090152A JP 9015292 A JP9015292 A JP 9015292A JP H07165709 A JPH07165709 A JP H07165709A
Authority
JP
Japan
Prior art keywords
tetrahydro
oxo
trimethyl
ethyl
benzazepine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4090152A
Other languages
English (en)
Japanese (ja)
Inventor
Michael Dr Kraus
ミヒヤエル・クラウス
Peter Mohr
ペーター・モール
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of JPH07165709A publication Critical patent/JPH07165709A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/12—1,5-Benzodiazepines; Hydrogenated 1,5-benzodiazepines

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Quinoline Compounds (AREA)
  • Indole Compounds (AREA)
JP4090152A 1991-03-21 1992-03-17 カルボキシアミド及びアニリドならびに医薬品へのその利用 Pending JPH07165709A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH86391 1991-03-21
CH00863/91-4 1991-03-21

Publications (1)

Publication Number Publication Date
JPH07165709A true JPH07165709A (ja) 1995-06-27

Family

ID=4196940

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4090152A Pending JPH07165709A (ja) 1991-03-21 1992-03-17 カルボキシアミド及びアニリドならびに医薬品へのその利用

Country Status (21)

Country Link
US (1) US5216148A (enrdf_load_stackoverflow)
EP (1) EP0504695A1 (enrdf_load_stackoverflow)
JP (1) JPH07165709A (enrdf_load_stackoverflow)
KR (1) KR920018029A (enrdf_load_stackoverflow)
AU (1) AU649308B2 (enrdf_load_stackoverflow)
BR (1) BR9200951A (enrdf_load_stackoverflow)
CA (1) CA2061662A1 (enrdf_load_stackoverflow)
CS (1) CS83892A3 (enrdf_load_stackoverflow)
FI (1) FI921135L (enrdf_load_stackoverflow)
HU (1) HUT60465A (enrdf_load_stackoverflow)
IE (1) IE920907A1 (enrdf_load_stackoverflow)
IL (1) IL101242A (enrdf_load_stackoverflow)
IS (1) IS3823A (enrdf_load_stackoverflow)
MX (1) MX9201143A (enrdf_load_stackoverflow)
MY (1) MY131268A (enrdf_load_stackoverflow)
NO (1) NO921105L (enrdf_load_stackoverflow)
NZ (1) NZ241953A (enrdf_load_stackoverflow)
TW (1) TW221425B (enrdf_load_stackoverflow)
UY (1) UY23386A1 (enrdf_load_stackoverflow)
YU (1) YU24792A (enrdf_load_stackoverflow)
ZA (1) ZA921889B (enrdf_load_stackoverflow)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003514022A (ja) * 1999-11-18 2003-04-15 アンテックスファーマ・インコーポレーテッド 置換された１−ベンズアゼピンとその誘導体
WO2005087220A1 (ja) * 2004-03-11 2005-09-22 R & R Inc. 抗しわ剤
JP2006522041A (ja) * 2003-03-31 2006-09-28 ユ セ ベ ソシエテ アノニム インドロンアセトアミド誘導体、その調製方法及びその使用
JP2012184225A (ja) * 2011-02-18 2012-09-27 Otsuka Pharmaceut Co Ltd 医薬組成物
JP2013502378A (ja) * 2009-08-21 2013-01-24 大塚製薬株式会社 窒素含有化合物及び医薬組成物

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5599548A (en) * 1995-05-08 1997-02-04 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing fatty acid amides and retinol or retinyl ester
ZA9610853B (en) 1995-12-29 1998-04-06 Smithkline Beecham Corp Processes and intermediates for preparing pharmaceuticals.
US5693330A (en) * 1996-04-25 1997-12-02 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing melinamide and a retinoid
US5716627A (en) * 1996-04-25 1998-02-10 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing fatty acid amides, azoles, and retinol or retinyl ester
US5747051A (en) * 1996-09-27 1998-05-05 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing an amide of a hydroxy fatty acid and a retinoid
US5955092A (en) * 1996-09-27 1999-09-21 Elizabeth Arden Co., Division Of Conopco, Inc. Skin care compositions containing an n-substituted fatty acid amide and retinol or retinyl ester
US20040176358A1 (en) * 1999-04-30 2004-09-09 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
US7144880B2 (en) 1999-04-30 2006-12-05 Regents Of The University Of Michigan Compositions relating to novel compounds and targets thereof
DK1143946T3 (da) * 1999-04-30 2004-06-07 Univ Michigan Anvendelse af benzodiazepiner til behandling af autoimmune sygdomme induceret af apoptose
US20050113460A1 (en) * 1999-04-30 2005-05-26 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
US20060025388A1 (en) 1999-04-30 2006-02-02 Glick Gary D Compositions and methods relating to novel compounds and targets thereof
US20050272723A1 (en) * 2004-04-27 2005-12-08 The Regents Of The University Of Michigan Methods and compositions for treating diseases and conditions associated with mitochondrial function
US20060052369A1 (en) * 2004-09-07 2006-03-09 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
EP1845996A4 (en) * 2005-01-03 2009-04-29 Univ Michigan COMPOSITIONS AND METHODS RELATED TO NEW CONNECTIONS AND TARGETS THEREFOR
US20070043033A1 (en) 2005-06-01 2007-02-22 The Regents Of The University Of Michigan Unsolvated benzodiazepine compositions and methods
US20070105844A1 (en) * 2005-10-26 2007-05-10 Regents Of The University Of Michigan Therapeutic compositions and methods
US8088759B2 (en) 2005-11-01 2012-01-03 The Regents Of The University Of Michigan 1,4-benzodiazepine-2,5-diones with therapeutic properties
US7759338B2 (en) * 2006-04-27 2010-07-20 The Regents Of The University Of Michigan Soluble 1,4 benzodiazepine compounds and stable salts thereof
CA2659549C (en) 2006-06-09 2013-07-30 The Regents Of The University Of Michigan Compositions and methods relating to novel compounds and targets thereof
KR101164718B1 (ko) 2007-03-09 2012-07-11 더 리젠츠 오브 더 유니버시티 오브 미시간 신규 화합물 및 이의 표적에 관한 조성물 및 방법
ES2614498T3 (es) 2007-09-14 2017-05-31 The Regents Of The University Of Michigan Inhibidores de ATPasa F1F0 y métodos relacionados
US8188072B2 (en) 2007-11-06 2012-05-29 The Regents Of The University Of Michigan Benzodiazepinone compounds useful in the treatment of skin conditions
KR101332948B1 (ko) 2008-02-22 2014-01-17 오츠카 세이야쿠 가부시키가이샤 벤조디아제핀 화합물 및 제약 조성물
AU2009291632B2 (en) 2008-09-11 2013-04-04 The Regents Of The University Of Michigan Aryl guanidine F1F0-ATPase inhibitors and related methods
US8604023B2 (en) 2009-04-17 2013-12-10 The Regents Of The University Of Michigan 1,4-benzodiazepinone compounds and their use in treating cancer
RU2553676C2 (ru) 2009-08-21 2015-06-20 Оцука Фармасьютикал Ко., Лтд. СПОСОБ ПОЛУЧЕНИЯ ПРОИЗВОДНОГО БЕНЗО[b][1,4]ДИАЗЕПИН-2,4-ДИОНА
EP2470020A4 (en) 2009-09-18 2013-03-13 Univ Michigan BENZODIAZEPINONE COMPOUNDS AND TREATMENT METHODS THEREWITH
EP2501387B1 (en) 2009-11-17 2016-07-27 The Regents Of The University Of Michigan 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
EP2501695B1 (en) 2009-11-17 2018-08-29 The Regents Of The University Of Michigan 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
CA2797694A1 (en) 2010-04-29 2011-11-03 The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services Activators of human pyruvate kinase

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0225464A (ja) * 1988-06-03 1990-01-26 Boehringer Mannheim Gmbh 二環式カルボキサミド、これを含有する、赤血球凝集または血小板凝集阻止作用を有する医薬、および該化合物製造の中間生成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3803775A1 (de) * 1988-02-09 1989-08-17 Boehringer Mannheim Gmbh Neue substituierte lactame, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten
AU626881B2 (en) * 1988-07-14 1992-08-13 F. Hoffmann-La Roche Ag Benzofused heterocyclics used as pharmaceuticals

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0225464A (ja) * 1988-06-03 1990-01-26 Boehringer Mannheim Gmbh 二環式カルボキサミド、これを含有する、赤血球凝集または血小板凝集阻止作用を有する医薬、および該化合物製造の中間生成物

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003514022A (ja) * 1999-11-18 2003-04-15 アンテックスファーマ・インコーポレーテッド 置換された１−ベンズアゼピンとその誘導体
JP2006522041A (ja) * 2003-03-31 2006-09-28 ユ セ ベ ソシエテ アノニム インドロンアセトアミド誘導体、その調製方法及びその使用
WO2005087220A1 (ja) * 2004-03-11 2005-09-22 R & R Inc. 抗しわ剤
JPWO2005087220A1 (ja) * 2004-03-11 2008-01-24 アールアンドアール株式会社 抗しわ剤
US8030360B2 (en) 2004-03-11 2011-10-04 Kemphys Ltd. Anti-wrinkle agent
JP2013502378A (ja) * 2009-08-21 2013-01-24 大塚製薬株式会社 窒素含有化合物及び医薬組成物
JP2012184225A (ja) * 2011-02-18 2012-09-27 Otsuka Pharmaceut Co Ltd 医薬組成物

Also Published As

Publication number Publication date
TW221425B (enrdf_load_stackoverflow) 1994-03-01
YU24792A (sh) 1994-09-09
MY131268A (en) 2007-07-31
UY23386A1 (es) 1992-11-05
IL101242A (en) 1995-12-08
CA2061662A1 (en) 1992-09-22
NO921105D0 (no) 1992-03-20
IS3823A (is) 1992-09-22
HU9200871D0 (en) 1992-05-28
ZA921889B (en) 1992-11-25
IE920907A1 (en) 1992-09-23
CS83892A3 (en) 1992-10-14
EP0504695A1 (de) 1992-09-23
NZ241953A (en) 1994-11-25
FI921135A7 (fi) 1992-09-22
FI921135A0 (fi) 1992-03-17
US5216148A (en) 1993-06-01
FI921135L (fi) 1992-09-22
IL101242A0 (en) 1992-11-15
HUT60465A (en) 1992-09-28
AU1108992A (en) 1992-09-24
MX9201143A (es) 1992-10-01
BR9200951A (pt) 1992-11-17
AU649308B2 (en) 1994-05-19
KR920018029A (ko) 1992-10-21
NO921105L (no) 1992-09-22

Similar Documents

Publication Publication Date Title
JPH07165709A (ja) カルボキシアミド及びアニリドならびに医薬品へのその利用
JP4490911B2 (ja) β−２アゴニストとしてのインドール誘導体
US4058558A (en) Aromatic keto acids and derivatives having analgetic, antiinflammatory, and hypocholesterolemizing action
US4008323A (en) Method of reducing cholesterol using certain aromatic keto acids
JPS5874667A (ja) １−シクロプロピル−６−フルオル−１，４−ジヒドロ−４−オキソ−７−ピペラジノキノリン−３−カルボン酸類
US3349088A (en) Therapeutically valuable 1, 2-dihyro-1, 2, 4-benzotriazine derivatives and process for preparation thereof
JPS5989625A (ja) 芳香族置換環状アミジン止瀉剤
HU197559B (en) Process for producing new aromatic carboxamide derivatives and pharmaceuticals comprising same as active ingredient
HU182570B (en) Process for producing quinoline-3-carboxylic acids
CZ8297A3 (en) Benzamidine, process of its preparation and pharmaceutical compositions containing thereof
PT87277B (pt) Processo para a preparacao de novos compostos biciclicos e composicoes farmaceuticas compreendendo os mesmos
EP0160578A1 (en) 1,8-Naphthyridine derivatives
NZ241197A (en) Substituted benz[b]azepine derivatives and pharmaceutical compositions
EP0055418B1 (en) Pyrazoline derivatives, processes for their preparation and pharmaceutical formulations containing them
US4801590A (en) Pyrido(1,8)naphthyridinones, and their use as pharmaceuticals
US4035368A (en) Substituted 3-(1H-tetrazol-5-yl)-quinoline compounds
US4555513A (en) 1,2 Dihydro- and 1,2,3,4-tetrahydro quinolylacetic acids and analgesic use thereof
JPS59193873A (ja) ヘテロ環化合物
US4886801A (en) Diazine-ethenylphenyl oxamic acids and esters and salts thereof
EP0137979B1 (en) Diazine-ethenylphenyl oxamic acids and esters and salts thereof
US4681884A (en) Diazine-ethenylphenyl oxamic acids and esters and salts thereof
SI9210247A (sl) Novi amidi karboksilne kisline
US4788198A (en) Diazine-ethyenylphenyl oxamic acids and esters and salts thereof
JPH04154736A (ja) ナフタレン誘導体
KR970011454B1 (ko) 신규의 아미드 화합물